友好
发表于 2025-3-26 22:57:19
http://reply.papertrans.cn/67/6638/663797/663797_31.png
Certainty
发表于 2025-3-27 05:04:25
http://reply.papertrans.cn/67/6638/663797/663797_32.png
榨取
发表于 2025-3-27 06:46:40
,Alzheimer’s Disease,treatments. Although disease modifying strategies are under study, the current therapies have not been shown to slow progression of the disease. Several lifestyle interventions that may have a pro-cognitive effect should be encouraged.
Atmosphere
发表于 2025-3-27 10:43:41
http://reply.papertrans.cn/67/6638/663797/663797_34.png
袭击
发表于 2025-3-27 13:44:01
,Parkinson’s Disease,tests that confirm the diagnosis of PD, however diagnosis is based on the presence of a constellation of symptoms including: bradykinesia, rigidity, tremor, and gait abnormality/postural instability. This chapter will review the current diagnostic criteria and approach to diagnosis and management of PD.
progestin
发表于 2025-3-27 20:59:21
http://reply.papertrans.cn/67/6638/663797/663797_36.png
NEX
发表于 2025-3-28 00:21:06
Book 2017gnostic criteria and immediately accessible visual care paths including the latest pharmacologic and non-pharmacologic interventions...Covering a range of modalities, from the importance and impact of each disease to diagnostic criteria, genetics, laboratory and imaging findings, treatment and care
独行者
发表于 2025-3-28 05:26:01
http://reply.papertrans.cn/67/6638/663797/663797_38.png
圆木可阻碍
发表于 2025-3-28 07:57:48
Office Approach to Neurological Disorders in the Elderly,ation of the potential etiology are addressed in this chapter. Finally, a clinically-guided supplementary testing approach related to the neurological chief complaint with a cost effective and confirmatory diagnostic purpose is also discussed.
Armada
发表于 2025-3-28 13:33:22
,Mild Cognitive Impairment and Prodromal Alzheimer’s Disease,er 50%. Prodromal Alzheimer’s disease is the specific type of cognitive impairment without functional decline that progresses to Alzheimer’s disease. Prodromal Alzheimer’s disease can be diagnosed by a combination of clinical assessment and the presence of an Alzheimer-type biomarker.